Explore GSK Pro
Therapy Areas
Explore Comprehensive Therapy Area Information for Healthcare Professionals.
Click Below to Access Detailed Insights
Featured sections
For more information, please refer to the prescribing information or contact GlaxoSmithKline via gcc.medinfo@gsk.com
To report Adverse Event/s associated with the use of GSK product/s, please contact us via
gulf.safety@gsk.com
To report quality complaint/s associated with the use of GSK product/s, please contact us via
Gulf.ProductQualityComplaints@gsk.com
Department of Pharmacovigilance & Drug Information |
دائرة التيقظ و المعلومات الدوائية مركز سلامة الدواء وزارة الصحة, سلطنة عمان هاتف: 0096822357687 / 0096822357690 0096822358489 :فاكس pharma-vigil@moh.gov.om :البريد الالكتروني https://moh.gov.om/en/ : الموقع الالكتروني |
Availability of GSK products varies by market. For registered products in your country, refer to the local prescribing information for details.
PM-AE-DV-WCNT-220001 Date of Preparation - August 2024